Literature DB >> 2188585

Effects of production of abnormal proteins on the rate of killing of Escherichia coli by streptomycin.

M A Wyka1, A C St John.   

Abstract

The role of abnormal membrane proteins in modulating the rate of killing by streptomycin was investigated. Davis et al. (B.D. Davis, L. Chen, and P.T. Tai, Proc. Natl. Acad. Sci. USA 83:6164-6168, 1986) have proposed that misread membrane proteins created by the action of streptomycin on translating ribosomes cause the formation of nonspecific membrane channels which allow increased uptake of the antibiotic and contribute to its bactericidal action. Pretreatment of Escherichia coli with a low concentration of puromycin enhanced the rate of killing by streptomycin. The effect of the pretreatment with puromycin was transient, since approximately normal rates of killing by streptomycin were restored after 30 min of incubation in antibiotic-free medium. This time period correlates with the time required to degrade labile polypeptides in puromycin-treated cells. The induction of a specific abnormal malE-lacZ fusion protein, which is capable of disrupting the normal membrane protein secretion process, also increased the rate of killing by streptomycin. Induction of malF-phoA fusion proteins, which have no significant effects on membrane integrity, did not alter susceptibility to streptomycin. These observations suggest that certain abnormal membrane proteins can contribute to the bactericidal action of streptomycin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188585      PMCID: PMC171639          DOI: 10.1128/AAC.34.4.534

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Use of gene fusion to study secretion of maltose-binding protein into Escherichia coli periplasm.

Authors:  P J Bassford; T J Silhavy; J R Beckwith
Journal:  J Bacteriol       Date:  1979-07       Impact factor: 3.490

2.  Non-specific membrane permeability and aminoglycoside action.

Authors:  B D Davis
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

3.  Respiration-dependent uptake of dihydrostreptomycin by Escherichia coli. Its irreversible nature and lack of evidence for a uniport process.

Authors:  W W Nichols; S N Young
Journal:  Biochem J       Date:  1985-06-01       Impact factor: 3.857

Review 4.  Intracellular protein degradation in mammalian and bacterial cells: Part 2.

Authors:  A L Goldberg; A C St John
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

Review 5.  Aminoglycoside uptake and mode of action--with special reference to streptomycin and gentamicin. I. Antagonists and mutants.

Authors:  R E Hancock
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

6.  Protein localization in E. coli: is there a common step in the secretion of periplasmic and outer-membrane proteins?

Authors:  K Ito; P J Bassford; J Beckwith
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

7.  Degradation of abnormal proteins in Escherichia coli (protein breakdown-protein structure-mistranslation-amino acid analogs-puromycin).

Authors:  A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

8.  Role of ribosome recycling in uptake of dihydrostreptomycin by sensitive and resistant Escherichia coli.

Authors:  C Hurwitz; C B Braun; C L Rosano
Journal:  Biochim Biophys Acta       Date:  1981-01-29

9.  Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.

Authors:  L E Bryan; H M Van Den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

Review 10.  Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells.

Authors:  R E Hancock
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

View more
  2 in total

1.  MexXY multidrug efflux system of Pseudomonas aeruginosa.

Authors:  Yuji Morita; Junko Tomida; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

2.  Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection.

Authors:  Ravikiran M Raju; Meera Unnikrishnan; Daniel H F Rubin; Vidhya Krishnamoorthy; Olga Kandror; Tatos N Akopian; Alfred L Goldberg; Eric J Rubin
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.